Akebia Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Akebia Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $148k | 112k | 1.32 |
| 2024-06-30 | $189k | 185k | 1.02 |
| 2024-03-31 | $407k | 222k | 1.83 |
| 2023-09-30 | $788k | 692k | 1.14 |
| 2023-06-30 | $349k | 381k | 0.92 |
| 2023-03-31 | $146k | 261k | 0.56 |
| 2022-12-31 | $35k | 61k | 0.58 |
| 2022-09-30 | $51k | 160k | 0.32 |
| 2022-06-30 | $29k | 81k | 0.36 |
| 2022-03-31 | $175k | 244k | 0.72 |
| 2021-12-31 | $594k | 263k | 2.26 |
| 2021-09-30 | $456k | 158k | 2.88 |
| 2021-06-30 | $316k | 83k | 3.79 |
| 2021-03-31 | $504k | 149k | 3.39 |
| 2020-12-31 | $674k | 241k | 2.80 |
| 2020-09-30 | $1.3M | 522k | 2.51 |
| 2020-06-30 | $2.6M | 193k | 13.58 |
| 2020-03-31 | $237k | 31k | 7.57 |
| 2019-12-31 | $496k | 79k | 6.32 |
| 2019-09-30 | $2.0k | 500 | 4.00 |
| 2019-06-30 | $10k | 2.0k | 5.00 |
| 2019-03-31 | $57k | 7.0k | 8.14 |
| 2018-12-31 | $221k | 40k | 5.54 |
| 2018-06-30 | $14k | 1.4k | 10.00 |
| 2018-03-31 | $241k | 25k | 9.53 |
| 2017-12-31 | $156k | 11k | 14.86 |
| 2017-09-30 | $6.0k | 300 | 20.00 |
| 2017-06-30 | $506k | 35k | 14.38 |
| 2017-03-31 | $280k | 30k | 9.21 |
| 2016-12-31 | $232k | 22k | 10.40 |
| 2016-09-30 | $100k | 11k | 9.09 |
| 2016-06-30 | $106k | 14k | 7.46 |
| 2016-03-31 | $328k | 36k | 9.01 |
| 2015-12-31 | $208k | 16k | 12.92 |
| 2015-09-30 | $297k | 31k | 9.67 |
| 2015-06-30 | $61k | 5.9k | 10.34 |
| 2015-03-31 | $61k | 5.5k | 11.09 |
| 2014-12-31 | $36k | 3.1k | 11.61 |
| 2014-09-30 | $144k | 6.5k | 22.15 |
Top funds holding Akebia Therapeutics
View all funds holding Akebia Therapeutics